TEVA PHARMACEUTICALS USA, INC. is associated with UEI NEN9A34LRHJ5 and CAGE 3V8D7 in public federal records. AcornBids currently links 96 prime awards totaling $67.0M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Pharmaceutical Preparation Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists PARSIPPANY, NJ, USA.
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 16, 2026. Refresh pending; these totals may be out of date.
Public SAM.gov registration details.
Source facts
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 96 of 96 selected awards. Select a period to explore its awards.
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| SPE2DP26F54658512097232!ADENOVIRUS TYPE 4 A | Department of Defense | $171.8K | May 11, 2026 | May 19, 2026 |
| SPE2DP26F54668512097239!ADENOVIRUS TYPE 4 A | Department of Defense | $1.0M | May 11, 2026 | May 19, 2026 |
| SPE2DP26F54678512097271!ADENOVIRUS TYPE 4 A | Department of Defense | $343.5K | May 11, 2026 | May 19, 2026 |
| SPE2DP26F54688512097273!ADENOVIRUS TYPE 4 A | Department of Defense | $343.5K | May 11, 2026 | May 19, 2026 |
| SPE2DP26F54698512097278!ADENOVIRUS TYPE 4 A | Department of Defense | $687.1K | May 11, 2026 | May 19, 2026 |
| SPE2DP26F54718512097411!ADENOVIRUS TYPE 4 A | Department of Defense | $515.3K | May 11, 2026 | May 19, 2026 |
| SPE2DP26F54728512097415!ADENOVIRUS TYPE 4 A | Department of Defense | $343.5K | May 11, 2026 | May 19, 2026 |
| SPE2DP26F54738512097419!ADENOVIRUS TYPE 4 A | Department of Defense | $515.3K | May 11, 2026 | May 19, 2026 |
| SPE2DP26F46328512041922!ADENOVIRUS TYPE 4 A | Department of Defense | $171.8K | Apr 15, 2026 | Apr 29, 2026 |
| SPE2DP26F46338512041924!ADENOVIRUS TYPE 4 A | Department of Defense | $1.0M | Apr 15, 2026 | Apr 29, 2026 |
| Registration evidence | Date |
|---|---|
| SAM updated | Jan 8, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | May 25, 2004 |
| Entity start | Jan 28, 1985 |
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| JESSICA CATALANO | Government business | Contact method not published | SAM registration | Not available |
| KARA O'BRIEN | Alternate government business | Contact method not published | SAM registration | Not available |
| JESSICA CATALANO | Electronic business | Contact method not published | SAM registration | Not available |
| KARA O'BRIEN | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Explore the customer, work and award-size evidence behind each match.
Recorded award industries: 325412 — Pharmaceutical Preparation Manufacturing.
Recorded products and services: 6505 — Drugs and Biologicals; AN95 — OTHER MEDICAL - OPERATIONAL SYSTEMS DEVELOPMENT.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
400 INTERPACE PKWY, PARSIPPANY, New Jersey 07054, United States
Registered location from SAM.gov; award performance locations may differ.
325412 — Pharmaceutical Preparation Manufacturing.
Primary SAM.gov NAICS classification.
Department of Defense.
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit